StonvexLoading…
StonvexStonvexStonvexCore line items from RDNT's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Q1 2026 2026-03-31 | Annual 2025 2025-12-31 | Q3 2025 2025-09-30 | Q2 2025 2025-06-30 |
|---|---|---|---|---|
Revenue | $575.63M | $2.04B | $1.49B | $969.63M |
Operating Income | $-23.90M | $61.99M | $34.17M | $6.78M |
Net Income | $-33.47M | $-18.65M | $-18.05M | $-23.47M |
EPS (Diluted) | $-0.43 | $-0.25 | $-0.24 | $-0.32 |
Total Assets | $3.89B | $3.76B | $3.67B | $3.51B |
Total Liabilities | $2.53B | $2.40B | $2.35B | $2.34B |
Cash & Equivalents | $455.34M | $767.22M | $804.72M | $833.15M |
Free Cash Flow OCF − CapEx | Not available | Not available | Not available | Not available |
Shares Outstanding | 78.55M | 77.40M | 77.03M | 75.07M |